Imexpharm Corporation reported VND2,205 billion (US$87.3 million) in net revenue for 2024, marking a 10.6% year-on-year ...

Venus Remedies has secured the renewal of its EU-GMP certification from Infarmed, Portugal, for its Cephalosporin, Carbapenem ...

Venus Remedies secures EU GMP renewal from Infarmed, strengthens European market presence: Our Bureau, Bengaluru Wednesday, January 22, 2025, 15:30 Hrs [IST] Venus Remedies has an ...

Venus Remedies secures renewed EU GMP certification for its manufacturing facility, enabling expansion in European and global ...

Aurora Cannabis (ACB) announces the launch of the company’s first German-cultivated medical cannabis product, under the brand IndiMed.

Leveraging HYTN’s GMP-certified facility and expertise in quality system development, SNDL will provide specialized equipment, cannabis consumables, and the required capital to meet stringent ...

Imexpharm Corporation has announced its 2024 financial results with net revenue reaching VND2,205 billion, up 10.6 percent year on year, driven by robust growth in ETC channel and high-quality ...

Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a market leader in premium cannabis and ...

格隆汇1月17日丨国药现代(600420.SH)公布，控股子公司国药集团致君（深圳）制药有限公司（简称国药致君），收到德国相关监管机构（BundesinstitutfürArzneimittelundMedizinprodukte，简称BfArM）颁 ...

智通财经APP讯，国药现代 (600420.SH)发布公告，公司控股子公司国药集团致君 (深圳)制药有限公司 (简称国药致君)，收到德国相关监管机构BfArM颁发的GMP证书，国药致君粉针一车间1线首次通过EU-GMP符合性检查。